Leerink Partners analyst Thomas Smith reiterated a Buy rating on Viridian Therapeutics (VRDN – Research Report) on November 12 and set a ...

H.C. Wainwright analyst Douglas Tsao maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) today and set a price ...

This darling stock is growing revenue at an extraordinary rate and believes it can grow at a greater than 20% annual rate ...

On Wednesday, major U.S. indices showed mixed results: the Dow Jones Industrial Average edged up 0.1% to close at 43,958.19.

Luminar Technologies is poised for future revenue growth with Volvo's EX90 and Iris LiDAR. See why LAZR stock could improve ...